Literature DB >> 28870084

Comparison Between Thromboelastography and Conventional Coagulation Tests in Surgical Patients With Localized Prostate Cancer.

Zhengwei Wang1, Jing Li2, Qingwei Cao3, Lei Wang1, Fengzhi Shan1, Houyi Zhang4.   

Abstract

We aimed to examine hypercoagulable and hypocoagulable conditions in patients with prostate cancer using thromboelastography (TEG) and correlate TEG parameters with conventional coagulation test. The t test was used for comparing TEG parameters and routine coagulation results. Spearman rank-order correlation was used to describe the relationship of TEG and conventional tests. Sensitivity, specificity, positive predictive values, and negative predictive values were determined for bleeding and thrombosis. Totally, 20 patients had active bleeding postoperatively, 16 of whom showed hypocoagulation on TEG test and 9 of whom showed hypocoagulation by routine coagulation test ( P = .024). Overall, 60 patients did not have active bleeding postoperatively, 51 of whom showed hypercoagulation detected by TEG test and 42 of whom showed hypercoagulation found by routine coagulation test ( P = .040). Remarkably, patients had a little higher fibrinogen (FIB) compared to controls. There was no statistical difference in any of the conventional coagulation indexes between the groups. Correlation analysis showed that reaction time (R) and coagulation time (K) were positively correlated with the prothrombin time-international normalized ratio (PT-INR) and negatively correlated with FIB ( P < .001). Contrarily, α-angle and maximum amplitude (MA) were negatively correlated with PT-INR but positively correlated with FIB. Significantly, MA showed the strongest correlation with FIB and R exhibited the strongest correlation with PT-INR. Sensitivity and specificity for bleeding and thrombosis in TEG were higher than those in conventional coagulation test. Accordingly, TEG might be superior in evaluating hypercoagulation and detecting the risk of bleeding in patients with prostate cancer.

Entities:  

Keywords:  coagulation function; correlation; prostate cancer; routine coagulation test; thrombelastography

Mesh:

Year:  2017        PMID: 28870084      PMCID: PMC6714867          DOI: 10.1177/1076029617724229

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  32 in total

1.  Thrombelastography in healthy volunteers, patients with stable angina and acute chest pain.

Authors:  R Artang; E Jensen; F Pedersen; N J Frandsen
Journal:  Thromb Res       Date:  2000-03-15       Impact factor: 3.944

2.  On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery.

Authors:  L Capraro; A Kuitunen; M Salmenperä; R Kekomäki
Journal:  Acta Anaesthesiol Scand       Date:  2001-02       Impact factor: 2.105

Review 3.  Thrombelastography.

Authors:  S V Mallett; D J Cox
Journal:  Br J Anaesth       Date:  1992-09       Impact factor: 9.166

4.  The measurement of multifactorial thrombophilia.

Authors:  P M Mannucci
Journal:  Thromb Haemost       Date:  2002-07       Impact factor: 5.249

5.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

Authors:  J A Heit; M D Silverstein; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  2000-03-27

6.  Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction.

Authors:  Douglas J McCrath; Elisabetta Cerboni; Robert J Frumento; Andrew L Hirsh; Elliott Bennett-Guerrero
Journal:  Anesth Analg       Date:  2005-06       Impact factor: 5.108

7.  Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia.

Authors:  L S Elting; E B Rubenstein; C G Martin; D Kurtin; S Rodriguez; E Laiho; K Kanesan; S B Cantor; R S Benjamin
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

8.  Efficacy of anticoagulants and platelet inhibitors in cancer-induced thrombosis.

Authors:  Melissa E Cloonan; Marianne DiNapoli; Shaker A Mousa
Journal:  Blood Coagul Fibrinolysis       Date:  2007-06       Impact factor: 1.276

Review 9.  Scoring systems for grading deep leg vein thrombosis.

Authors:  O Björgell; F Robertson
Journal:  Acta Radiol       Date:  2002-05       Impact factor: 1.990

10.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.

Authors:  Alok A Khorana; Charles W Francis; Eva Culakova; Nicole M Kuderer; Gary H Lyman
Journal:  Cancer       Date:  2007-11-15       Impact factor: 6.860

View more
  11 in total

1.  Huayu Wan Prevents Lewis Lung Cancer Metastasis in Mice via the Platelet Pathway.

Authors:  Yunfei Ma; Guangda Li; Xu Sun; Kexin Cao; Xiaomin Wang; Guowang Yang; Mingwei Yu
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-27       Impact factor: 2.629

2.  Assessment of hypercoagulability using thromboelastography predicts advanced status in renal cell carcinoma.

Authors:  Xun Wang; An Shi; Jiwei Huang; Yonghui Chen; Wei Xue; Jin Zhang
Journal:  J Clin Lab Anal       Date:  2019-08-22       Impact factor: 2.352

3.  Comparison of Thromboelastography and Conventional Coagulation Tests in Patients With Severe Liver Disease.

Authors:  Patryck Lloyd-Donald; Abhinav Vasudevan; Peter Angus; Paul Gow; Johan Mårtensson; Neil Glassford; Glenn M Eastwood; Graeme K Hart; Daryl Jones; Laurence Weinberg; Rinaldo Bellomo
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

4.  Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke Patients.

Authors:  Xuemei Quan; Qixiong Qin; Xianting Que; Ya Chen; Yunfei Wei; Hao Chen; Qianqian Li; Chaoguo Meng; Zhijian Liang
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

5.  Integral Use of Thromboelastography With Platelet Mapping to Guide Appropriate Treatment, Avoid Complications, and Improve Survival of Patients With Coronavirus Disease 2019-Related Coagulopathy.

Authors:  Tjasa Hranjec; Michael Estreicher; Bradley Rogers; Lisa Kohler; Rachele Solomon; Sara Hennessy; Megan Cibulas; Deborah Hurst; Mohamed Hegazy; Jieun Lee; Donny Perez; Norman Doctor; Chauniqua Kiffin; Danielle Pigneri; Heather LaGuardia; Kathryn Shaw; Juan Arenas; Andrew Rosenthal; Randy S Katz; Robert G Sawyer; Paul E Pepe
Journal:  Crit Care Explor       Date:  2020-12-21

6.  Gender Differences do not Influence the Blood Coagulopathy in Patients Undergoing Total Knee Arthroplasty: A Retrospective Thromboelastography Analysis.

Authors:  Wang-Yi Jin; Yong Pang; Xing-Chen Zhang; Da-Lin Peng; Zi-Wen Yan; Sheng Pan; Chao-Ran Huang; Kai-Jin Guo; Xin Zheng
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

7.  Thromboelastography Parameters as Predictors for Long-Term Survival in Critically Ill Patients.

Authors:  Cuizhu Luo; Bingjie Zhuang; Zhongqing Chen
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

8.  Comparison between thromboelastography and the conventional coagulation test in detecting effects of antiplatelet agents after endovascular treatments in acute ischemic stroke patients: A STROBE-compliant study.

Authors:  Chunyang Liang; Yang Yang; Zijun He; Shang Ma; Xuenan Qu; Yongchun Luo; Chunsen Shen; Ruxiang Xu
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

9.  The Value of Thromboelastography in the Diagnosis of Sepsis-Induced Coagulopathy.

Authors:  Cuizhu Luo; Hongbin Hu; Jian Gong; Yun Zhou; Zhongqing Chen; Shumin Cai
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

10.  Establishment of Normal Range for Thromboelastography in Healthy Middle-Aged and Elderly People of Weihai in China.

Authors:  Lina Ni; Peng Xue; Changjuan An; Xia Yu; Jiangli Qu; Yingjie Yao; Yingbo Li
Journal:  J Healthc Eng       Date:  2021-11-28       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.